Schedule 13D ownership disclosure

Liminal BioSciences Inc.

Security class unavailable · CUSIP: 53272L202

Event date: 2023-04-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
68.0900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-041878
Form type
SC 13D/A
Filer
Liminal BioSciences Inc.
CIK
CIK 1351172
Filed
Apr 05, 2023
Reporting period
Apr 04, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub